MYCN and cancer: One of the nine genes we confirmed to be repressed by both MYCN and TFAP4, CYLD, a deubiquitinating enzyme that negatively regulates NF-κB activation [24], is a well-established tumor suppressor gene, and loss of CYLD expression has been observed in various human cancer types [25].